Literature DB >> 26402756

Caffeine, Through Adenosine A3 Receptor-Mediated Actions, Suppresses Amyloid-β Protein Precursor Internalization and Amyloid-β Generation.

Shanshan Li, Nicholas H Geiger, Mahmoud L Soliman, Liang Hui, Jonathan D Geiger, Xuesong Chen.   

Abstract

Intraneuronal accumulation and extracellular deposition of amyloid-β (Aβ) protein continues to be implicated in the pathogenesis of Alzheimer's disease (AD), be it familial in origin or sporadic in nature. Aβ is generated intracellularly following endocytosis of amyloid-β protein precursor (AβPP), and, consequently, factors that suppress AβPP internalization may decrease amyloidogenic processing of AβPP. Here we tested the hypothesis that caffeine decreases Aβ generation by suppressing AβPP internalization in primary cultured neurons. Caffeine concentration-dependently blocked low-density lipoprotein (LDL) cholesterol internalization and a specific adenosine A3 receptor (A3R) antagonist as well as siRNA knockdown of A3Rs mimicked the effects of caffeine on neuronal internalization of LDL cholesterol. Further implicating A3Rs were findings that a specific A3R agonist increased neuronal internalization of LDL cholesterol. In addition, caffeine as well as siRNA knockdown of A3Rs blocked the ability of LDL cholesterol to increase Aβ levels. Furthermore, caffeine blocked LDL cholesterol-induced decreases in AβPP protein levels in neuronal plasma membranes, increased surface expression of AβPP on neurons, and the A3R antagonist as well as siRNA knockdown of A3Rs mimicked the effects of caffeine on AβPP surface expression. Moreover, the A3R agonist decreased neuronal surface expression of AβPP. Our findings suggest that caffeine exerts protective effects against amyloidogenic processing of AβPP at least in part by suppressing A3R-mediated internalization of AβPP.

Entities:  

Keywords:  Adenosine A3 receptor; Alzheimer’s disease; LDL cholesterol; amyloid-β; amyloid-β protein precursor; caffeine; endocytosis

Mesh:

Substances:

Year:  2015        PMID: 26402756      PMCID: PMC4609209          DOI: 10.3233/JAD-142223

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  54 in total

1.  Apolipoprotein B immunoreactivity in senile plaque and vascular amyloids and neurofibrillary tangles in the brains of patients with Alzheimer's disease.

Authors:  Y Namba; H Tsuchiya; K Ikeda
Journal:  Neurosci Lett       Date:  1992-01-06       Impact factor: 3.046

Review 2.  Normal and abnormal functions of adenosine receptors in the central nervous system revealed by genetic knockout studies.

Authors:  Catherine J Wei; Wei Li; Jiang-Fan Chen
Journal:  Biochim Biophys Acta       Date:  2010-12-23

Review 3.  Caffeine and coffee as therapeutics against Alzheimer's disease.

Authors:  Gary W Arendash; Chuanhai Cao
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

4.  Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology.

Authors:  Cyril Laurent; Sabiha Eddarkaoui; Maxime Derisbourg; Antoine Leboucher; Dominique Demeyer; Sébastien Carrier; Marion Schneider; Malika Hamdane; Christa E Müller; Luc Buée; David Blum
Journal:  Neurobiol Aging       Date:  2014-03-29       Impact factor: 4.673

5.  High Blood caffeine levels in MCI linked to lack of progression to dementia.

Authors:  Chuanhai Cao; David A Loewenstein; Xiaoyang Lin; Chi Zhang; Li Wang; Ranjan Duara; Yougui Wu; Alessandra Giannini; Ge Bai; Jianfeng Cai; Maria Greig; Elizabeth Schofield; Raj Ashok; Brent Small; Huntington Potter; Gary W Arendash
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

6.  Caffeine, an inhibitor of endocytosis in Dictyostelium discoideum amoebae.

Authors:  C Gonzalez; G Klein; M Satre
Journal:  J Cell Physiol       Date:  1990-09       Impact factor: 6.384

7.  Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.

Authors:  A M Cataldo; C M Peterhoff; J C Troncoso; T Gomez-Isla; B T Hyman; R A Nixon
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

Review 8.  Epidemiology of Alzheimer disease.

Authors:  Christiane Reitz; Carol Brayne; Richard Mayeux
Journal:  Nat Rev Neurol       Date:  2011-02-08       Impact factor: 42.937

9.  Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice.

Authors:  Gary W Arendash; Takashi Mori; Chuanhai Cao; Malgorzata Mamcarz; Melissa Runfeldt; Alexander Dickson; Kavon Rezai-Zadeh; Jun Tane; Bruce A Citron; Xiaoyang Lin; Valentina Echeverria; Huntington Potter
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

10.  Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's Disease.

Authors:  Peter Wostyn; Debby Van Dam; Kurt Audenaert; Peter Paul De Deyn
Journal:  Int J Alzheimers Dis       Date:  2011-05-26
View more
  12 in total

1.  Effect of Paullinia cupana Mart. Commercial Extract During the Aging of Middle Age Wistar Rats: Differential Effects on the Hippocampus and Striatum.

Authors:  Moara Rodrigues Mingori; Luana Heimfarth; Charles Francisco Ferreira; Henrique Mautone Gomes; Karla Suzana Moresco; Jeferson Delgado; Sabrina Roncato; Fares Zeidán-Chuliá; Daniel Pens Gelain; José Cláudio Fonseca Moreira
Journal:  Neurochem Res       Date:  2017-03-27       Impact factor: 3.996

Review 2.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

Review 3.  Neuroprotective Effect of Caffeine in Alzheimer's Disease.

Authors:  Y Mukish M Yelanchezian; Henry J Waldvogel; Richard L M Faull; Andrea Kwakowsky
Journal:  Molecules       Date:  2022-06-10       Impact factor: 4.927

4.  Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation.

Authors:  Mahmoud L Soliman; Jonathan D Geiger; Xuesong Chen
Journal:  J Neuroimmune Pharmacol       Date:  2016-09-15       Impact factor: 4.147

Review 5.  The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer's Disease.

Authors:  Lucrezia Cellai; Kevin Carvalho; Emilie Faivre; Aude Deleau; Didier Vieau; Luc Buée; David Blum; Céline Mériaux; Victoria Gomez-Murcia
Journal:  Front Neurosci       Date:  2018-08-03       Impact factor: 4.677

Review 6.  Research progress on adenosine in central nervous system diseases.

Authors:  Ying-Jiao Liu; Jiao Chen; Xun Li; Xin Zhou; Yao-Mei Hu; Shi-Feng Chu; Ye Peng; Nai-Hong Chen
Journal:  CNS Neurosci Ther       Date:  2019-07-23       Impact factor: 5.243

7.  Combined Effect Of Coffee Consumption And Cigarette Smoking On Serum Levels Of Vitamin B12, Folic Acid, And Lipid Profile In Young Male: A Cross-Sectional Study.

Authors:  May Abu-Taha; Rajaa Dagash; Beisan A Mohammad; Iman Basheiti; Mahmoud S Abu-Samak
Journal:  Int J Gen Med       Date:  2019-11-22

8.  Coffee intake and decreased amyloid pathology in human brain.

Authors:  Jee Wook Kim; Min Soo Byun; Dahyun Yi; Jun Ho Lee; So Yeon Jeon; Gijung Jung; Han Na Lee; Bo Kyung Sohn; Jun-Young Lee; Yu Kyeong Kim; Seong A Shin; Chul-Ho Sohn; Dong Young Lee
Journal:  Transl Psychiatry       Date:  2019-10-22       Impact factor: 6.222

9.  Apolipoprotein E isoform dependently affects Tat-mediated HIV-1 LTR transactivation.

Authors:  Nabab Khan; Gaurav Datta; Jonathan D Geiger; Xuesong Chen
Journal:  J Neuroinflammation       Date:  2018-03-20       Impact factor: 8.322

10.  Methylxanthines: Potential Therapeutic Agents for Glioblastoma.

Authors:  Daniel Pérez-Pérez; Iannel Reyes-Vidal; Elda Georgina Chávez-Cortez; Julio Sotelo; Roxana Magaña-Maldonado
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.